Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33611805

Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2021 Jul
First author
Xu J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Xu J
      type
      Author
    2. name
      Xie L
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Liu K
      type
      Author
    5. name
      Tang X
      type
      Author
    6. name
      Yan T
      type
      Author
    7. name
      Yang R
      type
      Author
    8. name
      Guo W
      type
      Author
    9. name
      Gu J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Xu J
      type
      Author
    2. name
      Xie L
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Liu K
      type
      Author
    5. name
      Tang X
      type
      Author
    6. name
      Yan T
      type
      Author
    7. name
      Yang R
      type
      Author
    8. name
      Guo W
      type
      Author
    9. name
      Gu J
      type
      Author
    bibliography ids
    1. nci-bib-fb1095e84a47a311cdb93ce6
    book metadata
    content sha256
    1858ac97bd0bb4c4ea6d945b3b089607b335b8da6050b3732e85c103a029f754
    document type
    citation
    dois
    1. 10.1002/onco.13726
    electronic publication date
    display
    2021 Mar 8
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33611805
    immutable id
    pubmed:33611805@1858ac97bd0bb4c4ea6d945b3b089607b335b8da6050b3732e85c103a029f754
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    7
    name
    The oncologist
    nlm unique id
    9607837
    pages
    e1256-e1262
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33611805
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      ed651c88d1df4c92e62b19979c58f77eb602eddfa260c09dd25f3e1935b49b33
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Jul
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33611805/
      title
      Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial.

      Preserved source evidence · Not medical advice